Troubled healthcare firm looking to secure future with funding

Manchester based healthcare firm WideCells has warned that it will be forced to introduce cost cutting measures after suffering a torrid year. The firm, which focusses on providing stem cell services and insurance for stem cell treatment, has announced its interim results for the six months. Over the period there was minimal revenues which led to a loss of £2.03m. Costs included over £390,000 relating to the aborted acquisitions and three attempts to raise capital. There were also reorganisation costs of £130,000. Under... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...